NCT06342336View on ClinicalTrials.gov

HS-IT101 Injection in the Treatment of Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2028

Conditions
Solid Tumor
Interventions
DRUG

HS-IT101 Injection

Adoptive transfer of 5x10\^9-6x10\^10 autologous TIL to patients i.v. in 30-60 minutes.

Trial Locations (1)

100021

RECRUITING

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

The First Hospital of Jilin University

OTHER

collaborator

West China Hospital

OTHER

lead

Qingdao Sino-Cell Biomedicine Co., Ltd.

INDUSTRY